Extended-release dewormer in palatable tablets scored on both sides .
Package containing 1 blister with 2 tablets.
Broad-spectrum dewormer.
Fenbendazole: It acts by binding to tubulin, a protein that makes up the parasite microtubules, inhibiting the parasite glucose uptake, which causes loss of energy and death.
Pyrantel: It stimulates acetylcholine release, inhibiting the cholyntesterase and provoking a neuromuscular blockade in helminths. In consequence, it causes the paralysis and detachment of parasites.
Praziquantel: It increases the permeability to calcium in the parasite, producing spastic paralysis and tissue damage.
Prevention and treatment of cestodes, nematodes. Cestodes: Dipylidium caninum, Taenia spp. Nematodes: Toxocara cati, Toxascarias leonina, Ancylostoma spp.
Each tablet contains:
Fenbendazole 200 mg
Pyrantel base (pamoate) 80 mg
Praziquantel 20 mg
Excipients q.s.
One tablet every 4 kg of bodyweight, equivalent to:
Praziquantel: 5 mg/kg of bodyweight Pyrantel base (pamoate): 20 mg/kg of bodyweight
Fenbendazole: 50 mg/kg of bodyweight.
Single administration. In severe infestations, repeat the dose after 24 hours Repeat the deworming after 15 – 21 days.
Do not administer to animals with a known sensitivity to any of the main ingredients.
Occasionally, there may be hypersalivation, nausea, vomiting or diarrhea, which remit spontaneously. Sensitive cats can rarely experience episodes of lethargy and ataxia.
Kittens younger than 20 days. Pregnant cats until gestational day 41.
Use with caution in animals with liver and kidney failure, and in debilitated and convalescent animals.